FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Edge Pharma Betadine Recall

Betadine (Povidone-Iodine) 5%, 0

Edge Pharma, LLC · Colchester, VT

Risk level
Class II
Reported by FDA
Apr 28, 2021
Recall ID
D-0335-2021
Check your lot numberHow we source this data

Summary

Edge Pharma recalled Betadine starting Apr 12, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0335-2021 on Apr 28, 2021. Reason: Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility. Status: Terminated.

Why it was recalled

Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility

Product description

Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178

Lot numbers, UPCs & expiration codes

Lot 02-2021-16@4 BUD 5/31/2021

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0335-2021
Classification
Class II
Status
Terminated
Recall initiated
Apr 12, 2021
FDA report date
Apr 28, 2021
Quantity
5850 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Edge Pharma, LLC

Original FDA data

Every field from FDA enforcement report D-0335-2021, exactly as published.

Show all FDA fields
City
Colchester
State
VT
Status
Terminated
Country
United States
Event ID
87710
Address
856 Hercules Dr
Code information
Lot 02-2021-16@4 BUD 5/31/2021
Postal code
05446-8014
Report date
Apr 28, 2021
Product type
Drugs
Recall number
D-0335-2021
Classification
Class II
Recalling firm
Edge Pharma, LLC
Product quantity
5850 syringes
Termination date
Feb 11, 2022
Reason for recall
Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178
Distribution pattern
Nationwide in the US
Recall initiation date
Apr 12, 2021
Initial firm notification
Letter
Center classification date
Apr 19, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0335-2021, published Apr 28, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls